Manulife (Manufacturers Life Insurance)’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-22,983
Closed -$2.62M 2905
2024
Q4
$2.62M Buy
22,983
+2,054
+10% +$234K ﹤0.01% 1447
2024
Q3
$2.49M Buy
+20,929
New +$1.92M ﹤0.01% 1478
2023
Q1
Sell
-34,999
Closed -$5.36M 2939
2022
Q4
$5.36M Sell
34,999
-18,832
-35% -$2.9M ﹤0.01% 1040
2022
Q3
$7.19M Buy
53,831
+5,920
+12% +$905K 0.01% 900
2022
Q2
$6.8M Sell
47,911
-9,056
-16% -$1.38M ﹤0.01% 950
2022
Q1
$9.96M Buy
+56,967
New +$9.57M 0.01% 905

Other funds holding BNTX

Manulife (Manufacturers Life Insurance)'s BNTX Position: Q1 2025 in Review

Manulife (Manufacturers Life Insurance) sold out of BioNTech (BNTX) in Q1 2025, closing a stake of 22,983 shares — an estimated $2.62M sold.

Manulife (Manufacturers Life Insurance) first reported a position in BNTX in Q1 2022 and held it in 6 quarters. The position peaked at $9.96M in Q1 2022. 280 funds tracked by Wall St. Rank hold BNTX as of Q1 2025.

  • Manulife (Manufacturers Life Insurance) reported no remaining BioNTech position as of Q1 2025 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 22,983 BioNTech shares in Q1 2025, an estimated $2.62M.
  • Manulife (Manufacturers Life Insurance) first reported a position in BioNTech in Q1 2022 and held it in 6 quarters.
  • Manulife (Manufacturers Life Insurance)'s BioNTech position peaked at $9.96M in Q1 2022.
  • 280 funds tracked by Wall St. Rank held BioNTech as of Q1 2025.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2025, filed 15 May 2025.